SynBiotic SE (ETR:SBX)
Germany · Delayed Price · Currency is EUR 3.060
+0.035 (1.14%)
Jul 23, 2025, 5:36 PM CET
SynBiotic SE Company Description
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names.
The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2017 and is based in Munich, Germany.
SynBiotic SE
| Country | Germany |
| Founded | 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Daniel Kruse |
Contact Details
Address: Barer Strasse 7 Munich, 80333 Germany | |
| Website | synbiotic.com |
Stock Details
| Ticker Symbol | SBX |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A3E5A59 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Kruse | Managing Director |